Assignation to treatment dosage by treating centres. The table shows number of patients assigned to either Rebif dosage at each of the participating centres. Odds relative to the reference centre (IT-
To evaluate 96-week virologic, immunologic, resistance and metabolic outcomes of bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) in antiretroviral therapy (ART)-naïve people li